VERACYTE INC (VCYT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:VCYT • US92337F1075

36.19 USD
+1.33 (+3.82%)
At close: Feb 6, 2026
36.36 USD
+0.17 (+0.47%)
After Hours: 2/6/2026, 8:10:18 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Overall VCYT gets a fundamental rating of 6 out of 10. We evaluated VCYT against 523 industry peers in the Biotechnology industry. VCYT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. VCYT is growing strongly while it is still valued neutral. This is a good combination! These ratings could make VCYT a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • VCYT had positive earnings in the past year.
  • In the past year VCYT had a positive cash flow from operations.
  • VCYT had negative earnings in 4 of the past 5 years.
  • In multiple years VCYT reported negative operating cash flow during the last 5 years.
VCYT Yearly Net Income VS EBIT VS OCF VS FCFVCYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • VCYT has a better Return On Assets (2.22%) than 89.33% of its industry peers.
  • Looking at the Return On Equity, with a value of 2.41%, VCYT belongs to the top of the industry, outperforming 90.29% of the companies in the same industry.
  • VCYT has a better Return On Invested Capital (2.93%) than 90.10% of its industry peers.
Industry RankSector Rank
ROA 2.22%
ROE 2.41%
ROIC 2.93%
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
VCYT Yearly ROA, ROE, ROICVCYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • With an excellent Profit Margin value of 6.12%, VCYT belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
  • With an excellent Operating Margin value of 9.70%, VCYT belongs to the best of the industry, outperforming 91.62% of the companies in the same industry.
  • VCYT has a Gross Margin of 68.53%. This is amongst the best in the industry. VCYT outperforms 81.14% of its industry peers.
  • In the last couple of years the Gross Margin of VCYT has remained more or less at the same level.
Industry RankSector Rank
OM 9.7%
PM (TTM) 6.12%
GM 68.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
VCYT Yearly Profit, Operating, Gross MarginsVCYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VCYT is destroying value.
  • The number of shares outstanding for VCYT has been increased compared to 1 year ago.
  • Compared to 5 years ago, VCYT has more shares outstanding
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VCYT Yearly Shares OutstandingVCYT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VCYT Yearly Total Debt VS Total AssetsVCYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • VCYT has an Altman-Z score of 15.97. This indicates that VCYT is financially healthy and has little risk of bankruptcy at the moment.
  • VCYT has a Altman-Z score of 15.97. This is amongst the best in the industry. VCYT outperforms 87.05% of its industry peers.
  • VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.97
ROIC/WACC0.24
WACC12.44%
VCYT Yearly LT Debt VS Equity VS FCFVCYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • VCYT has a Current Ratio of 6.23. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of VCYT (6.23) is better than 63.81% of its industry peers.
  • VCYT has a Quick Ratio of 5.94. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
  • VCYT has a Quick ratio of 5.94. This is in the better half of the industry: VCYT outperforms 63.24% of its industry peers.
Industry RankSector Rank
Current Ratio 6.23
Quick Ratio 5.94
VCYT Yearly Current Assets VS Current LiabilitesVCYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 353.33%, which is quite impressive.
  • VCYT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.41%.
  • VCYT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.93% yearly.
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%

3.2 Future

  • Based on estimates for the next years, VCYT will show a very strong growth in Earnings Per Share. The EPS will grow by 51.21% on average per year.
  • VCYT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.52% yearly.
EPS Next Y78.93%
EPS Next 2Y94.08%
EPS Next 3Y63.11%
EPS Next 5Y51.21%
Revenue Next Year15.05%
Revenue Next 2Y13.16%
Revenue Next 3Y12.77%
Revenue Next 5Y11.52%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
VCYT Yearly Revenue VS EstimatesVCYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
VCYT Yearly EPS VS EstimatesVCYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 95.24, VCYT can be considered very expensive at the moment.
  • VCYT's Price/Earnings ratio is rather cheap when compared to the industry. VCYT is cheaper than 89.71% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of VCYT to the average of the S&P500 Index (27.93), we can say VCYT is valued expensively.
  • The Price/Forward Earnings ratio is 32.03, which means the current valuation is very expensive for VCYT.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 91.81% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of VCYT to the average of the S&P500 Index (27.77), we can say VCYT is valued inline with the index average.
Industry RankSector Rank
PE 95.24
Fwd PE 32.03
VCYT Price Earnings VS Forward Price EarningsVCYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, VCYT is valued cheaper than 92.38% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, VCYT is valued cheaply inside the industry as 94.10% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 29.2
EV/EBITDA 34.84
VCYT Per share dataVCYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of VCYT may justify a higher PE ratio.
  • A more expensive valuation may be justified as VCYT's earnings are expected to grow with 63.11% in the coming years.
PEG (NY)1.21
PEG (5Y)N/A
EPS Next 2Y94.08%
EPS Next 3Y63.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for VCYT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VERACYTE INC

NASDAQ:VCYT (2/6/2026, 8:10:18 PM)

After market: 36.36 +0.17 (+0.47%)

36.19

+1.33 (+3.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04
Earnings (Next)02-25
Inst Owners114.83%
Inst Owner Change-2.02%
Ins Owners0.42%
Ins Owner Change-3.94%
Market Cap2.86B
Revenue(TTM)495.14M
Net Income(TTM)30.31M
Analysts82.11
Price Target49.7 (37.33%)
Short Float %6.58%
Short Ratio6.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)0.75%
PT rev (3m)15.74%
EPS NQ rev (1m)3.75%
EPS NQ rev (3m)12.59%
EPS NY rev (1m)1.2%
EPS NY rev (3m)34.36%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)1.09%
Revenue NY rev (1m)0.48%
Revenue NY rev (3m)1.92%
Valuation
Industry RankSector Rank
PE 95.24
Fwd PE 32.03
P/S 5.78
P/FCF 29.2
P/OCF 26.56
P/B 2.27
P/tB 7.19
EV/EBITDA 34.84
EPS(TTM)0.38
EY1.05%
EPS(NY)1.13
Fwd EY3.12%
FCF(TTM)1.24
FCFY3.42%
OCF(TTM)1.36
OCFY3.77%
SpS6.26
BVpS15.91
TBVpS5.04
PEG (NY)1.21
PEG (5Y)N/A
Graham Number11.66
Profitability
Industry RankSector Rank
ROA 2.22%
ROE 2.41%
ROCE 3.71%
ROIC 2.93%
ROICexc 4.08%
ROICexgc 54.52%
OM 9.7%
PM (TTM) 6.12%
GM 68.53%
FCFM 19.79%
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 44.07%
Cap/Sales 1.97%
Interest Coverage 250
Cash Conversion 153.6%
Profit Quality 323.21%
Current Ratio 6.23
Quick Ratio 5.94
Altman-Z 15.97
F-Score8
WACC12.44%
ROIC/WACC0.24
Cap/Depr(3y)39.24%
Cap/Depr(5y)36.19%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y78.93%
EPS Next 2Y94.08%
EPS Next 3Y63.11%
EPS Next 5Y51.21%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
Revenue Next Year15.05%
Revenue Next 2Y13.16%
Revenue Next 3Y12.77%
Revenue Next 5Y11.52%
EBIT growth 1Y427.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year320.9%
EBIT Next 3Y74.34%
EBIT Next 5Y48.27%
FCF growth 1Y236.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.39%
OCF growth 3YN/A
OCF growth 5YN/A

VERACYTE INC / VCYT FAQ

What is the fundamental rating for VCYT stock?

ChartMill assigns a fundamental rating of 6 / 10 to VCYT.


What is the valuation status of VERACYTE INC (VCYT) stock?

ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.


How profitable is VERACYTE INC (VCYT) stock?

VERACYTE INC (VCYT) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for VCYT stock?

The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 95.24 and the Price/Book (PB) ratio is 2.27.


What is the financial health of VERACYTE INC (VCYT) stock?

The financial health rating of VERACYTE INC (VCYT) is 8 / 10.